|
|
| MRD / Regn No. |
: MH/23-24/00208 |
Date |
: 17/06/2026 |
| Patient Name |
: David |
Age & Gender |
: 43 Yrs. / Male |
| Contact No. |
: 9944848847 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NO ALLERGIES |
Referred By |
: |
| |
|
| Problem
List |
: |
MODY (17/Aug/2023) | |
|
Subjective |
: |
GEN ITCHING BOTH LEGS |
| Salient Investigations |
: |
HBA1C GLYCOSYLATED HEMOGLOBIN: 6.4 mg/dL | FASTING PLASMA GLUCOSE (FPG): 117 mg/dL | TOTAL CHOLESTEROL: 114 1 | TGL TRIGLYCERIDE: 53 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 41 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 83 mg/dL | UREA: 41 mg/dL | CREATININE: 1.0 1 | EGFR EGLOMERULAR FILTRATION RATE: 86.82 mL/min/1.73m2 | TSH THYROID STIMULATING HORMONE: 1.150 mIU/L | TOTAL BILIRUBIN: 0.24 mg/dL | AST ASPARTATE AMINOTRANSFERASE: 24 U/L | ALT ALANINE AMINOTRANSFERASE: 21 IU/L | ALKALINE PHOSPHOTASE: 64 IU/L | ALBUMIN: 4.6 g/dL | GLOBULIN: 2.9 | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
DAPAGLIFLOZIN + SITAGLIPTIN
GLUXIT-S |
ORAL |
1-0-0 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
2 |
PIOGLITAZONE 7.5 MG
PIOZ 7.5 MG |
|
0-0-1 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
3 |
TABLET GLIMEPRIDE 2 +METFORMIN 500 + VOGLIBOSE 0.2
GLIMIWINDAR TRIO 2 |
ORAL |
1-0-1 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
4 |
TABLET ROSUVASTATIN 5 MG
ROSUWIN 5
Medicine For CHOLESTROL/HEART |
ORAL |
0-0-1 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 17/Jul/2026 |
| Tests Suggested For Next Visit |
: |
| |
|
| |
|
